RTW INVESTMENTS, LP - PROTEOSTASIS THERAPEUTICS IN ownership

PROTEOSTASIS THERAPEUTICS IN's ticker is PTI and the CUSIP is 74373B109. A total of 54 filers reported holding PROTEOSTASIS THERAPEUTICS IN in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
RTW INVESTMENTS, LP ownership history of PROTEOSTASIS THERAPEUTICS IN
ValueSharesWeighting
Q4 2018$1,016,000
-62.7%
313,466
-72.2%
0.10%
-41.7%
Q3 2018$2,721,000
-9.5%
1,129,121
+4.8%
0.16%
-24.9%
Q2 2018$3,006,000
-42.7%
1,077,408
-2.5%
0.22%
-56.5%
Q1 2018$5,248,000
-40.0%
1,104,940
-26.3%
0.50%
-65.8%
Q4 2017$8,745,0001,500,0001.46%
Other shareholders

There were no reported owners of PROTEOSTASIS THERAPEUTICS IN in Q4 2017.

NameSharesValueWeighting ↓
View complete list of PROTEOSTASIS THERAPEUTICS IN shareholders